FDA Inspection
Rocky Mountain Tissue BankRocky Mountain Tissue Bank – FDA Inspection, Oct 24, 2016
Record Details
This FDA Inspection record concerns Rocky Mountain Tissue Bank, with an inspection on October 24, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 60ff9dbd-00ec-43e4-b0f4-e26db833c2ca
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 997992
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Rocky Mountain Tissue Bank
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 4, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 17, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 22, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 22, 2013 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 15, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Rocky Mountain Tissue Bank
- FDA Inspection 1233237 - 2024-03-04
- FDA Inspection 1071051 - 2018-10-17
- FDA Inspection 900994 - 2014-10-22
- FDA Inspection 823145 - 2013-02-22
- FDA Inspection 709950 - 2011-02-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.